The KAAACI Guidelines for Sublingual Immunotherapy.

Authors:
Min JY; Jee HM; Lee HY; Kang SY; Kim K and 23 more

Journal:
Allergy Asthma Immunol Res

Publication Year: 2024

DOI:
10.4168/aair.2024.16.1.9

PMCID:
PMC10823141

PMID:
38262388

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Allergy Asthma Immunol Res

Abbreviation: Allergy Asthma Immunol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
LincR-PPP2R5C Promotes Th2 Cell Differentiation Through PPP2R5C/PP2A by Forming an RNA-DNA Triplex …
Ji N; Chen Z; Wang Z and 14 more (2024) - Transparency Score: 3/6
Sputum Transcriptomics Reveals FCN1+ Macrophage Activation in Mild Eosinophilic Asthma Compared to …
Zhan W; Luo W; Zhang Y and 10 more (2024) - Transparency Score: 4/6
ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled …
Quoc QL; Cao TBT; Jang JH and 3 more (2024) - Transparency Score: 4/6
Suppression of SPARC Ameliorates Ovalbumin-induced Airway Remodeling via TGFβ1/Smad2 in Chronic Ast…
Pan Y; Zhang D; Zhang J and 7 more (2024) - Transparency Score: 3/6
A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination.
Choi JH; Chung SJ. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: There are no financial or other issues that might lead to conflict of interest."

Evidence found in paper:

"This guideline for AIT was developed with the support of the KAAACI. The authors would like to thank all members of the Allergen Immunotherapy and Allergen working group at the KAAACI. This study was supported by a grant from the KAAACI in 2022. This guideline for AIT was developed with the support of the KAAACI. The authors would like to thank all members of the Allergen Immunotherapy and Allergen working group at the KAAACI. This study was supported by a grant from the KAAACI in 2022."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025